Literature DB >> 2390476

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.

G Blanco1, K Holli, M Heikkinen, O P Kallioniemi, P Taskinen.   

Abstract

Site of first recurrence, disease-free interval (DFI), female sex steroid receptors, ploidy measurements as well as histological grading have been analysed as potentially valuable predictive factors in 313 cases of recurrent breast cancer. Univariate and multivariate analyses show histological grading, site of recurrence and disease free interval to be useful prognostic variables when assessing prognosis once disease has recurred. High concentrations of oestrogen receptors (ER) were found in patients with bone metastases, whereas lower concentrations of ER were related to visceral recurrences. Ploidy measurements failed in this study to give any predictive information once disease recurred.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390476      PMCID: PMC1971734          DOI: 10.1038/bjc.1990.247

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Advanced breast cancer: are the traditional stratification parameters still of value when patients are treated with combination chemotherapy?

Authors:  P Valagussa; C Brambilla; G Bonadonna
Journal:  Eur J Cancer       Date:  1979-04       Impact factor: 9.162

2.  Classification of patients with disseminated cancer of the breast.

Authors:  S J Cutler; J A Ardyce; S G Taylor
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

3.  The enigmatic behavior of breast cancer.

Authors:  J E Devitt
Journal:  Cancer       Date:  1971-01       Impact factor: 6.860

4.  Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy.

Authors:  C H Nash; S E Jones; T E Moon; S L Davis; S E Salmon
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

5.  The natural history of breast cancer patients with brain metastases.

Authors:  A DiStefano; Y Yong Yap; G N Hortobagyi; G R Blumenschein
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

6.  Relationship between primary breast tumor receptor status and patient survival.

Authors:  R W Blamey; H M Bishop; J R Blake; P J Doyle; C W Elston; J L Haybittle; R I Nicholson; K Griffiths
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

7.  Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.

Authors:  O P Kallioniemi; G Blanco; M Alavaikko; T Hietanen; J Mattila; K Lauslahti; M Lehtinen; T Koivula
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  Prognostic factors in mammary carcinoma.

Authors:  A Wallgren; C Silfverswärd; G Eklund
Journal:  Acta Radiol Ther Phys Biol       Date:  1976-02

9.  Relationship of oestrogen-receptor status to survival in breast cancer.

Authors:  H M Bishop; R W Blamey; C W Elston; J L Haybittle; R I Nicholson; K Griffiths
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  17 in total

Review 1.  Prognostic factors and survival in metastatic breast cancer: A single institution experience.

Authors:  Afef Khanfir; Faiez Lahiani; Racem Bouzguenda; Ines Ayedi; Jamel Daoud; Mounir Frikha
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-14

2.  Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity.

Authors:  Rebecca Lamb; Sophie Lehn; Lynsey Rogerson; Robert B Clarke; Göran Landberg
Journal:  Cell Cycle       Date:  2013-06-26       Impact factor: 4.534

Review 3.  Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions.

Authors:  Andrea Milani; Elena Geuna; Gloria Mittica; Giorgio Valabrega
Journal:  World J Clin Oncol       Date:  2014-12-10

4.  Prognostic factors for bone metastases in breast cancer.

Authors:  M A Ulloa; E C Merchan
Journal:  Int Orthop       Date:  1993       Impact factor: 3.075

5.  Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.

Authors:  J F Robertson; A R Dixon; R I Nicholson; I O Ellis; C W Elston; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 6.  DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.

Authors:  D W Hedley; G M Clark; C J Cornelisse; D Killander; T Kute; D Merkel
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

7.  Human breast cancer: survival from first metastasis. Breast Cancer Study Group.

Authors:  P G Koenders; L V Beex; P W Kloppenborg; A G Smals; T J Benraad
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.

Authors:  Yiduo Liu; Linxin Teng; Shiyi Fu; Guiyang Wang; Zhengjun Li; Chao Ding; Haodi Wang; Lei Bi
Journal:  BMC Cancer       Date:  2021-05-31       Impact factor: 4.430

9.  Prognostic factors at the time of diagnosis of metastatic breast cancer.

Authors:  J F Robertson; R W Blamey
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

10.  Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation.

Authors:  J van der Zee; B van der Holt; P J Rietveld; P A Helle; A J Wijnmaalen; W L van Putten; G C van Rhoon
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.